Are we entering a new era for clinical data analysis? An era in which massive time savings, quality improvements, and cost savings can be achieved by automation of the production of tables, listings, and figures...
Complete the form to download the case study to explore how Blur™ enabled secure, efficient data sharing while protecting patient privacy and supporting clinical transparency.
Read our blog post to learn about the top eight features that biostatistics professionals value most in a clinical data analysis system, and why they matter in today’s landscape of clinical trial analytics.
In this blog post, we’ll explore what automated clinical trial data reporting entails, why it matters, and how your organization can benefit from adopting this technology sooner rather than later.
Don’t let validation burdens, disjointed systems, access mismanagement, and audit preparedness delay your Biostatistics workflows. With an easy and compliant solution, you can solve all of these problems.
The European Medicines Agency (EMA) recently launched new rules with its EMA Policy 0070 Step 2. This update strengthens and expands clinical trial transparency rules, protecting patient privacy and commercially confidential information.
